BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Francardo V, Geva M, Bez F, et al. (2019) Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics
Lerner RP, Francardo V, Fujita K, et al. (2017) Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia. Scientific Reports. 7: 16005
Francardo V, Schmitz Y, Sulzer D, et al. (2017) Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease. Experimental Neurology
Bez F, Francardo V, Cenci MA. (2016) Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion. Neurobiology of Disease
Shen W, Plotkin JL, Francardo V, et al. (2016) M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia. Neuron. 90: 1139
Marongiu R, Arango-Lievano M, Francardo V, et al. (2016) Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice. Proceedings of the National Academy of Sciences of the United States of America
Shen W, Plotkin JL, Francardo V, et al. (2015) M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia. Neuron. 88: 762-773
Janelidze S, Lindqvist D, Francardo V, et al. (2015) Increased CSF biomarkers of angiogenesis in Parkinson disease. Neurology
Cenci MA, Francardo V, O'Sullivan SS, et al. (2015) Rodent models of impulsive-compulsive behaviors in Parkinson's disease: How far have we reached? Neurobiology of Disease. 82: 561-73
Bastide MF, Meissner WG, Picconi B, et al. (2015) Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology
See more...